Rochester Family Eye Clinic Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3630 11th Ave Nw, Rochester, MN 55901 Phone: 507-288-2457 Fax: 507-288-1299 |
Dominic A Miron, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3632 10th Ln Nw, Rochester, MN 55901 Phone: 507-282-7121 Fax: 507-285-0951 |
Dr. Tom Sczepanski Eye Care, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3400 55th St Nw, Walmart North, Rochester, MN 55901 Phone: 507-280-8438 Fax: 507-280-9284 |
Maria Annum, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3462 55th St Nw Ste 600, Rochester, MN 55901 Phone: 507-206-5047 |
Dr. Roshani Patel Sellon, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 25 25th St Se, Wal-mart South Vision Center, Rochester, MN 55904 Phone: 507-292-1729 Fax: 507-292-1731 |
Jackie Cohrs, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |
You And Eye Family Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 2650 Broadway Ave S Ste 400, Rochester, MN 55904 Phone: 507-322-0044 Fax: 507-322-0046 |
Mrs. Melissa K Downs, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3630 11th Ave Nw, Rochester, MN 55901 Phone: 507-288-2457 Fax: 507-288-1299 |
Dr. Danial Yusufzai, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3462 55th St Nw Ste 600, Rochester, MN 55901 Phone: 507-206-5047 |
Barbara Tylka, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |
News Archive
Researchers at Washington University School of Medicine in St. Louis appear to have discovered a way to make radiation therapy for colorectal cancer more effective by inhibiting a protein found in cancer cells in the gut.
A new therapy to re-activate silenced genes in patients who suffer from neurodegenerative diseases or stroke is being developed by researchers at the University of Illinois at Chicago and Cornell University.
Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging study of its lead drug candidate, AMA0076 for the treatment of glaucoma.
As the nationwide opioid epidemic continues, more young people are developing a life-threatening heart infection that can result from drug abuse.
› Verified 8 days ago